166 related articles for article (PubMed ID: 25064172)
1. DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence.
Benard A; Zeestraten EC; Goossens-Beumer IJ; Putter H; van de Velde CJ; Hoon DS; Kuppen PJ
Apoptosis; 2014 Nov; 19(11):1581-93. PubMed ID: 25064172
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence.
de Maat MF; van de Velde CJ; van der Werff MP; Putter H; Umetani N; Klein-Kranenbarg EM; Turner RR; van Krieken JH; Bilchik A; Tollenaar RA; Hoon DS
J Clin Oncol; 2008 May; 26(14):2327-35. PubMed ID: 18467724
[TBL] [Abstract][Full Text] [Related]
3. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
4. Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer.
de Maat MF; van de Velde CJ; Benard A; Putter H; Morreau H; van Krieken JH; Meershoek Klein-Kranenbarg E; de Graaf EJ; Tollenaar RA; Hoon DS
Clin Cancer Res; 2010 May; 16(10):2811-8. PubMed ID: 20460484
[TBL] [Abstract][Full Text] [Related]
5. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
6. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables.
Schwandner O; Schiedeck TH; Bruch HP; Duchrow M; Windhoevel U; Broll R
Dis Colon Rectum; 2000 Sep; 43(9):1227-36. PubMed ID: 11005488
[TBL] [Abstract][Full Text] [Related]
8. Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers.
Exner R; Pulverer W; Diem M; Spaller L; Woltering L; Schreiber M; Wolf B; Sonntagbauer M; Schröder F; Stift J; Wrba F; Bergmann M; Weinhäusel A; Egger G
Br J Cancer; 2015 Sep; 113(7):1035-45. PubMed ID: 26335606
[TBL] [Abstract][Full Text] [Related]
9. The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study.
Abdul-Jalil KI; Sheehan KM; Toomey S; Schmid J; Prehn J; O'Grady A; Cummins R; O'Neill B; McNamara DA; Deasy J; Breathnach O; Grogan L; Rogers A; Doherty G; Winter D; Ryan J; El-Masry S; Gibbons D; Sheahan K; Gillen P; Kay EW; Hennessy BT
Ann Surg Oncol; 2014 Aug; 21(8):2642-9. PubMed ID: 24700299
[TBL] [Abstract][Full Text] [Related]
10. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.
Rödel F; Hoffmann J; Grabenbauer GG; Papadopoulos T; Weiss C; Günther K; Schick C; Sauer R; Rödel C
Strahlenther Onkol; 2002 Aug; 178(8):426-35. PubMed ID: 12240548
[TBL] [Abstract][Full Text] [Related]
11. p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer.
Schwandner O; Schiedeck TH; Bruch HP; Duchrow M; Windhoevel U; Broll R
Eur J Cancer; 2000 Feb; 36(3):348-56. PubMed ID: 10708936
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer.
Benard A; van de Velde CJ; Lessard L; Putter H; Takeshima L; Kuppen PJ; Hoon DS
Br J Cancer; 2013 Dec; 109(12):3073-83. PubMed ID: 24220694
[TBL] [Abstract][Full Text] [Related]
13. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
14. High intrinsic apoptosis, but not radiation-induced apoptosis, predicts better survival in rectal carcinoma patients.
Marijnen CA; Nagtegaal ID; Mulder-Stapel AA; Schrier PI; van de Velde CJ; van Krieken JH; Peltenburg LT
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):434-43. PubMed ID: 12957255
[TBL] [Abstract][Full Text] [Related]
15. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
[TBL] [Abstract][Full Text] [Related]
16. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of residual rectal carcinoma following preoperative radiochemotherapy.
Micev M; Micev-Cosić M; Todorović V; Krsmanović M; Krivokapić Z; Popović M; Barisić G; Marković V; Jelić-Radosević L; Popov I
Acta Chir Iugosl; 2004; 51(2):99-108. PubMed ID: 15771300
[TBL] [Abstract][Full Text] [Related]
19. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.
Shabo I; Olsson H; Sun XF; Svanvik J
Int J Cancer; 2009 Oct; 125(8):1826-31. PubMed ID: 19582880
[TBL] [Abstract][Full Text] [Related]
20. Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.
Sheu MJ; Chou CL; Yang CC; Lee SW; Tian YF; Lin CY; Hsiao SY; Chen SH; Huang WT
Pathol Res Pract; 2020 May; 216(5):152922. PubMed ID: 32249003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
